NewsRoom Articles - Page 81 of 154 - PsychedelicNewsWire (PNW)

ThursdayOct 21, 2021 11:30 am

The Psychedelics Sector Could Revolutionize Work

The psychedelics industry is flourishing and growing at a rapid rate as more states move to decriminalize the substances while others push for legalization. In the last few years, the market has seen significant growth in the number of drug-development companies that seek to get psychedelic compounds to be approved by the FDA. Projections show that in the next five years, psilocybin, which is the main active ingredient in magic mushrooms, and MDMA, which is also known as ecstasy, will be legal for prescription. Various studies have found that these substances possess medicinal benefits that may help treat various mental…

WednesdayOct 20, 2021 2:45 pm

Study Finds That Pain Distribution Could Influence Patient Outcomes

A new study has found that reporting pain distribution on a map can help classify patients into subgroups that are linked to differences in pain impact, pain quality, pain intensity and clinically relevant outcomes. The study’s findings were published in the “Plos One” journal. Normally, the distribution of chronic pain across an individual’s body is used together with other symptoms and signs to diagnose and treat patients. Recent research on fibromyalgia shows that pain syndromes that are typically viewed as separate entities may share relevant features, particularly regarding the influence of the distribution of pain on outcomes. For their study,…

WednesdayOct 20, 2021 1:42 pm

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Files Patent Application Amid ‘New Era’ of Psychedelic Medicine

Substances such as psilocybin, ketamine and LSD are edging into mainstream culture, setting the stage for a paradigm shift in modern medicine Cybin has filed an international patent application covering methods for the delivery of psychedelic medications by inhalation The company is pursuing the effectiveness of using inhalation as a delivery method for psychedelic medications Earlier this month, a Time magazine article reported on the “new era” of psychedelic medicine (https://ibn.fm/bfC3u). On the leading edge of this collective breakthrough is Cybin (NEO: CYBN) (NYSE American: CYBN), a company focused on progressing psychedelic therapeutics, addressing the mental health crisis and transforming the…

TuesdayOct 19, 2021 12:30 pm

Study Finds MDMA-Assisted Psychotherapy Improves Sleep in PTSD Patients

A new study has found that MDMA-assisted psychotherapy may improve sleep in PTSD patients. The study’s findings were reported in the “Journal of Traumatic Stress.” Study author L. Jerome of the MAPS Public Benefit Corporation stated that the researchers were interested in learning whether MDMA-assisted therapy could decrease sleep difficulties in individuals with post-traumatic stress disorder and who suffer from disrupted sleep as a result. Jerome explained that being hypervigilant and having intrusive thoughts made it hard for individuals to get sleep, noting that slumber could also be interrupted by nightmares associated with trauma. In the report, she observed that…

MondayOct 18, 2021 2:00 pm

Another California City Approves Measure to Decriminalize Psychedelic Substances

Last week, the city council of Arcata, California, decriminalized psychedelic substances. The measure, which was approved in a unanimous vote, will make the distribution, growing and possession of entheogenic substances such as ayahuasca and psilocybin among the lowest law-enforcement priorities in the city. This is in addition to calling upon the district attorney of Humboldt County to consider the measure’s intent when deciding whether to prosecute individuals involved in the use of entheogenic fungi and plants. The initiative further states that driving under the influence as well as the manufacturing and commercial sale of psychedelic substances remains prohibited. In an…

FridayOct 15, 2021 11:00 am

Why We Should Change How We View Psychedelic-Assisted Psychotherapy

Research on psychedelics began long before the substances were made illegal in the 1970s. When they were banned, the promising research on the substances ground to a halt — until recently. The current search for alternative and effective treatments for various mental health conditions has renewed interest in these substances, which have been used by different Indigenous communities for centuries. Now, more people are opening up to the idea of psychedelic substances being used in combination with psychotherapy to treat mental health disorders. Psychedelic substances, which are sometimes referred to as hallucinogens, cause hallucinations. Examples of these substances include ayahuasca,…

FridayOct 15, 2021 9:00 am

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Partners with University of Wisconsin Researchers for Clinical Pharmacology Studies Evaluating TRP-8803

Tryp Therapeutics has partnered with Dr. Paul Hutson and Dr. Christopher Nicholas, researchers at the University of Wisconsin-Madison The collaboration will focus on a clinical pharmacology studies to evaluate the safety and pharmacokinetics of TRP-8803, Tryp’s proprietary drug formulation The partnership is the latest in a series of collaborations as the company prepares for Phase 2b trials Tryp intends to use data from its Phase 2a clinical studies, expected to launch this year, coupled with preclinical data and clinical pharmacology data for TRP-8803, to support the use of the novel drug formulation in Phase 2b trials Tryp Therapeutics (CSE: TRYP)…

ThursdayOct 14, 2021 12:15 pm

Official Tells Legislators That VA Is Following Psychedelics Studies for Veterans

During a recent Congressional hearing, Rep. Colin Allred revealed that the Department of Veterans Affairs (“VA”) has closely been following studies on the therapeutic benefits of psychedelic substances such as MDMA for veterans. The meeting, which was held last month before the House Veterans’ Affairs Committee, focused on innovative approaches to deal with suicide prevention in veterans. Officials had asked for an update on the study evaluating the use of psychedelic substances for the treatment of PTSD in military veterans, noting that there were good results from prior research on how psychedelic substances could help alleviate the mental health struggles…

WednesdayOct 13, 2021 2:45 pm

Seattle Decriminalizes Psychedelics, Becomes Largest American City to Do So

At the start of this week, the city council of Seattle approved a measure to decriminalize non-commercial activity of psychedelics, which includes the sharing and cultivation of substances such as mescaline that haven’t been derived from peyote, ibogaine, ayahuasca and magic mushrooms. This resolution extends the city’s already existing policy to not prosecute or arrest individuals for drug possession and protect the sharing and growing of psychedelic fungi and plants for personal growth, healing, spiritual or religious practices. The measure, which was approved unanimously, stipulates that the arrest or prosecution of any person engaging in entheogen-related activities should be one…

TuesdayOct 12, 2021 2:15 pm

New Hampshire’s Youngest Legislator Calls for Psilocybin Decriminalization

The New Hampshire state legislature is presently under Republican control, which has made it harder for legislators to end marijuana prohibition and establish a regulated sales system. Despite this, Rep. Tony Labranche, one of the youngest state lawmakers in the United States, is calling for the decriminalization of psilocybin and all illicit substances. During an interview last week, the representative spoke about his plans to end the criminalization of individuals who possess or use psilocybin mushrooms in addition to generally decriminalizing the possession of controlled substances. He stated that it was the right thing to do because any individual who…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000